Your browser doesn't support javascript.
loading
Community-Wide Experimental Evaluation of the PROSS Stability-Design Method.
Peleg, Yoav; Vincentelli, Renaud; Collins, Brett M; Chen, Kai-En; Livingstone, Emma K; Weeratunga, Saroja; Leneva, Natalya; Guo, Qian; Remans, Kim; Perez, Kathryn; Bjerga, Gro E K; Larsen, Øivind; Vanek, Ondrej; Skorepa, Ondrej; Jacquemin, Sophie; Poterszman, Arnaud; Kjær, Svend; Christodoulou, Evangelos; Albeck, Shira; Dym, Orly; Ainbinder, Elena; Unger, Tamar; Schuetz, Anja; Matthes, Susann; Bader, Michael; de Marco, Ario; Storici, Paola; Semrau, Marta S; Stolt-Bergner, Peggy; Aigner, Christian; Suppmann, Sabine; Goldenzweig, Adi; Fleishman, Sarel J.
Afiliación
  • Peleg Y; Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: yoav.peleg@weizmann.ac.il.
  • Vincentelli R; Unité Mixte de Recherche (UMR) 7257, Centre National de la Recherche Scientifique (CNRS) Aix-Marseille Université, Architecture et Fonction des Macromolécules Biologiques (AFMB), Marseille, France.
  • Collins BM; The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia.
  • Chen KE; The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia.
  • Livingstone EK; The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia.
  • Weeratunga S; The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia.
  • Leneva N; The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia.
  • Guo Q; The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia.
  • Remans K; European Molecular Biology Laboratory (EMBL), Protein Expression and Purification Core Facility, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Perez K; European Molecular Biology Laboratory (EMBL), Protein Expression and Purification Core Facility, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Bjerga GEK; NORCE Norwegian Research Centre, Postboks 22 Nygårdstangen, 5038 Bergen, Norway.
  • Larsen Ø; NORCE Norwegian Research Centre, Postboks 22 Nygårdstangen, 5038 Bergen, Norway.
  • Vanek O; Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840 Prague, Czech Republic.
  • Skorepa O; Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840 Prague, Czech Republic.
  • Jacquemin S; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique (CNRS), UMR 7104, Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Université de Strasbourg, France.
  • Poterszman A; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique (CNRS), UMR 7104, Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Université de Strasbourg, France.
  • Kjær S; Structural Biology Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Christodoulou E; Structural Biology Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Albeck S; Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Dym O; Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Ainbinder E; Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Unger T; Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Schuetz A; Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany.
  • Matthes S; Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany.
  • Bader M; Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany; University of Lübeck, Institute for Biology, Ratzeburger Allee 160, 23562 Lübeck, Germany; Charité University Medicine, Charitéplatz 1, 10117 Berlin, Germany; German Center for Cardiovascular Resea
  • de Marco A; Laboratory for Environmental and Life Sciences, University of Nova Gorica, Slovenia.
  • Storici P; Elettra Sincrotrone Trieste - SS 14 - km 163, 5 in Area Science Park, 34149 Basovizza, Trieste, Italy.
  • Semrau MS; Elettra Sincrotrone Trieste - SS 14 - km 163, 5 in Area Science Park, 34149 Basovizza, Trieste, Italy.
  • Stolt-Bergner P; Vienna Biocenter Core Facilities GmbH, Dr. Bohr-gasse 3, 1030 Vienna, Austria.
  • Aigner C; Vienna Biocenter Core Facilities GmbH, Dr. Bohr-gasse 3, 1030 Vienna, Austria.
  • Suppmann S; Max-Planck Institute of Biochemistry, Biochemistry Core Facility, Am Klopferspitz 18, 82152 Martinsried, Germany.
  • Goldenzweig A; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Fleishman SJ; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: sarel.fleishman@weizmann.ac.il.
J Mol Biol ; 433(13): 166964, 2021 06 25.
Article en En | MEDLINE | ID: mdl-33781758
ABSTRACT
Recent years have seen a dramatic improvement in protein-design methodology. Nevertheless, most methods demand expert intervention, limiting their widespread adoption. By contrast, the PROSS algorithm for improving protein stability and heterologous expression levels has been successfully applied to a range of challenging enzymes and binding proteins. Here, we benchmark the application of PROSS as a stand-alone tool for protein scientists with no or limited experience in modeling. Twelve laboratories from the Protein Production and Purification Partnership in Europe (P4EU) challenged the PROSS algorithm with 14 unrelated protein targets without support from the PROSS developers. For each target, up to six designs were evaluated for expression levels and in some cases, for thermal stability and activity. In nine targets, designs exhibited increased heterologous expression levels either in prokaryotic and/or eukaryotic expression systems under experimental conditions that were tailored for each target protein. Furthermore, we observed increased thermal stability in nine of ten tested targets. In two prime examples, the human Stem Cell Factor (hSCF) and human Cadherin-Like Domain (CLD12) from the RET receptor, the wild type proteins were not expressible as soluble proteins in E. coli, yet the PROSS designs exhibited high expression levels in E. coli and HEK293 cells, respectively, and improved thermal stability. We conclude that PROSS may improve stability and expressibility in diverse cases, and that improvement typically requires target-specific expression conditions. This study demonstrates the strengths of community-wide efforts to probe the generality of new methods and recommends areas for future research to advance practically useful algorithms for protein science.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Algoritmos / Estabilidad Proteica Tipo de estudio: Prognostic_studies Idioma: En Revista: J Mol Biol Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Algoritmos / Estabilidad Proteica Tipo de estudio: Prognostic_studies Idioma: En Revista: J Mol Biol Año: 2021 Tipo del documento: Article